Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on July 2, 2025
ITECS Launches Comprehensive AI Consulting Services to Help Dallas Businesses Navigate the AI Revolution
EIN Presswire
·
July 2, 2025
ITECS expands AI consulting services with security-first approach, helping Dallas businesses implement AI solutions backed by 20+ years of IT expertise. DALLAS, TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- As businesses across Dallas and beyond …
Hundreds Attend 2025 Alzheimer’s Expo
EIN Presswire
·
July 2, 2025
The successful third edition of the Expo reveals an increased demand for information and resources among people affected by a growing disease. WACO, TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- The 2025 McLennan County Alzheimer’s Expo, held …
Dr. Dayan Goodenowe Announces ALS Health Challenge for All Residents of Saskatchewan Canada Living with ALS
EIN Presswire
·
July 2, 2025
MOOSE JAW, TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- The Dr. Goodenowe ALS Challenge is a new province-wide initiative to improve the health of persons suffering from ALS. The program offers free community-based health optimization services …
Sterling Staffing Solutions Named a 2025 Best Family-Owned Business by Houston Business Journal
EIN Presswire
·
July 2, 2025
Sterling Staffing Solutions has been honored as one of the Houston Business Journal’s 2025 Best Family-Owned Businesses. HOUSTON, TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Maceo Carter Investments, LLC, doing business as Sterling Staffing …
Channel Futures 2025 MSP 501 List Features Centre Technologies
EIN Presswire
·
July 2, 2025
Local IT company, Centre Technologies, has been recognized by the Channel Futures MSP 501 on their annual list of the best MSPs worldwide for the third time. HOUSTON, TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Centre Technologies has been …
TMF Health Quality Institute Continues Partnership with Meals on Wheels Central Texas
EIN Presswire
·
July 2, 2025
AUSTIN, TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- TMF Health Quality Institute, a leading non-profit health care consulting company based in Austin, has a long history of corporate sponsorship and volunteer support for Meals on Wheels Central …
Dr. Jay Barnett Inks Major Penguin Random House Deal for Powerful Book on Exhaustion and Healing
EIN Presswire
·
July 2, 2025
Dr. Jay’s new book offers a powerful framework for overcoming burnout, embracing rest, and guiding readers toward lasting healing and emotional renewal. DALLAS , TX, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Acclaimed author, licensed therapist, …
Range Impact Announces Expansion of Investment in its Fola Mine Complex with Acquisition of Two Mining Permits and Two Coal Leases
GlobeNewswire
·
July 2, 2025
CLEVELAND, OHIO, July 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mines throughout Appalachia, today announced the …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 2, 2025
BOSTON, July 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 2, 2025
WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 2, 2025
SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Oragenics Completes Approximately $16.5 Million Offering
GlobeNewswire
·
July 2, 2025
SARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously …
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
GlobeNewswire
·
July 2, 2025
FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced …
Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry
GlobeNewswire
·
July 2, 2025
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a …
Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
GlobeNewswire
·
July 2, 2025
GAITHERSBURG, Md., July 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the expansion of its proprietary NARCANDirect® online distribution network to include KLOXXADO® (naloxone HCl) Nasal Spray 8 mg. The platform …
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 2, 2025
PASADENA, CALIF, July 02, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a private placement with accredited investors for the purchase and …
4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution
GlobeNewswire
·
July 2, 2025
4FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 2027 4FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns with focused pipeline shift, as announced in January 2025 …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
July 2, 2025
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on July 1, 2025 the Company granted inducement awards to purchase up …
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
GlobeNewswire
·
July 2, 2025
WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the closing of …
Inventiva annonce la publication dans le Journal of Hepatology Reports des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH et dans des modèles précliniques de la maladie
GlobeNewswire
·
July 2, 2025
L'analyse des cellules endothéliales sinusoïdales hépatiques (« LSEC ») dans les biopsies de screening et de fin de traitement dans l'étude de Phase 2b NATIVE a mis en évidence une capillarisation des LSEC chez les patients atteints de MASLD, avec une …